Impact of group IVA cytosolic phospholipase A 2 gene polymorphisms on phenotypic features of patients with familial adenomatous polyposis

International Journal of Colorectal Disease

Volumn 25, Issue 3, 2010, Pages 293-301

  Umeno, Junji ^a   Matsumoto, Takayuki ^a   Esaki, Motohiro ^a   Kukita, Yoji ^b   Tahira, Tomoko ^b   Yanaru Fujisawa, Ritsuko ^a   Nakamura, Shotaro ^a   Arima, Hisatomi ^a   Hirahashi, Minako ^a   Hayashi, Kenshi ^b   Iida, Mitsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Familial adenomatous polyposis; Genotype phenotype correlation; Group IVA cytosolic phospholipase A2; Modifier gene

Indexed keywords

APC PROTEIN; CYTOSOLIC PHOSPHOLIPASE A2;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COLON POLYPOSIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; DESMOID TUMOR; FAMILIAL COLON POLYPOSIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INTESTINE POLYP; JAPANESE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; OSTEOMA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH POLYPOSIS;

ADENOMATOUS POLYPOSIS COLI; ADENOMATOUS POLYPOSIS COLI PROTEIN; ADOLESCENT; ADULT; AGED; ALLELES; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GROUP IV PHOSPHOLIPASES A2; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 77649231929     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-009-0808-x     Document Type: Article

References (40)

1. I Nishisho Y Nakamura Y Miyoshi, et al. 1991 Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients Science 253 665 669 10.1126/science.1651563 1:CAS:528:DyaK3MXmt1Gitr0%3D 1651563 (Pubitemid 21917200)
2. L Spirio B Otterud D Stauffer, et al. 1992 Linkage of a variant or attenuated form of adenomatous polyposis coli to the adenomatous polyposis coli (APC) locus Am J Hum Genet 51 92 100 1:STN:280:DyaK38zgtlGrsg%3D%3D 1319115
3. P Galiatsatos WD Foulkes 2006 Familial adenomatous polyposis Am J Gastroenterol 101 385 398 10.1111/j.1572-0241.2006.00375.x 16454848 (Pubitemid 43381685)
4. KP Nugent RK Phillips SV Hodgson, et al. 1994 Phenotypic expression in familial adenomatous polyposis: partial prediction by mutation analysis Gut 35 1622 1623 10.1136/gut.35.11.1622 1:STN:280:DyaK2M7ivF2ksA%3D%3D 7828985
5. DR Davies JG Armstrong N Thakker, et al. 1995 Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene Am J Hum Genet 57 1151 1158 1:STN:280:DyaK28%2Fis1Wisw%3D%3D 7485167
6. L Bertario A Russo P Sala, et al. 2003 Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis J Clin Oncol 21 1698 1707 10.1200/JCO.2003.09.118 1:CAS:528: DC%2BD2cXpsVWqsbs%3D 12721244 (Pubitemid 46638580)
7. M Leppert R Burt JP Hughes, et al. 1990 Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps N Engl J Med 322 904 908 1:STN:280:DyaK3c7ptVOksg%3D%3D 2156161
8. P Paul T Letteboer L Gelbert, et al. 1993 Identical APC exon 15 mutations result in a variable phenotype in familial adenomatous polyposis Hum Mol Genet 2 925 931 10.1093/hmg/2.7.925 1:CAS:528:DyaK3sXms1Olu74%3D 8395941
9. FM Giardiello SR Hamilton AJ Krush, et al. 1993 Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis N Engl J Med 328 1313 1316 10.1056/NEJM199305063281805 1:STN:280:DyaK3s3is1Sjtg%3D%3D 8385741 (Pubitemid 23131373)
10. G Steinbach PM Lynch RK Phillips, et al. 2000 The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis N Engl J Med 342 1946 1952 10.1056/NEJM200006293422603 1:CAS:528:DC%2BD3cXltVCnu7Y%3D 10874062 (Pubitemid 30419089)
11. JK Grover S Yadav V Vats, et al. 2003 Cyclo-oxygenase 2 inhibitors: emerging roles in the gut Int J Colorectal Dis 18 279 291 1:STN:280: DC%2BD3s3kvF2isA%3D%3D 12774242
12. CS Richard T Berk BV Bapat, et al. 1997 Sulindac for periampullary polyps in FAP patients Int J Colorectal Dis 12 14 18 10.1007/s003840050071 1:STN:280:DyaK2s3ms1emsg%3D%3D 9112144 (Pubitemid 27138352)
13. RK Phillips MH Wallace PM Lynch, et al. 2002 A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis Gut 50 857 860 10.1136/gut.50.6.857 1:CAS:528:DC%2BD38XkvVGktL8%3D 12010890 (Pubitemid 34539050)
14. G Huls JJ Koornstra JH Kleibeuker 2003 Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas Lancet 362 230 232 10.1016/S0140-6736(03)13915-3 1:CAS:528:DC%2BD3sXls1Cjtb4%3D 12885487 (Pubitemid 36859943)
15. R Yanaru-Fujisawa T Matsumoto Y Kukita, et al. 2007 Impact of phospholipase A2 group IIa gene polymorphism on phenotypic features of patients with familial adenomatous polyposis Dis Colon Rectum 50 223 231 10.1007/s10350-006-0780-2 17164967 (Pubitemid 46227220)
16. M Ghosh DE Tucker SA Burchett, et al. 2006 Properties of the group IV phospholipase A2 family Prog Lipid Res 45 487 510 10.1016/j.plipres.2006.05.003 1:CAS:528:DC%2BD28Xptlyru78%3D 16814865 (Pubitemid 44331412)
17. Y Kita T Ohto N Uozumi, et al. 2006 Biochemical properties and pathophysiological roles of cytosolic phospholipase A2s Biochim Biophys Acta 1761 1317 1322 1:CAS:528:DC%2BD28Xht1CisLvE 16962823 (Pubitemid 44738706)
18. F Bartoli HK Lin F Ghomashchi, et al. 1994 Tight binding inhibitors of 85-kDa phospholipase A2 but not 14-kDa phospholipase A2 inhibit release of free arachidonate in thrombin-stimulated human platelets J Biol Chem 269 15625 15630 1:CAS:528:DyaK2cXltlSku7Y%3D 8195211
19. Z Ni NM Okeley BP Smart, et al. 2006 Intracellular actions of group IIA secreted phospholipase A2 and group IVA cytosolic phospholipase A2 contribute to arachidonic acid release and prostaglandin production in rat gastric mucosal cells and transfected human embryonic kidney cells J Biol Chem 281 16245 16255 10.1074/jbc.M513874200 1:CAS:528:DC%2BD28XlsV2lsr0%3D 16603549 (Pubitemid 43909572)
20. KH Hong JC Bonventre E O'Leary, et al. 2001 Deletion of cytosolic phospholipase A(2) suppresses Apc(Min)-induced tumorigenesis Proc Natl Acad Sci U S A 98 3935 3939 10.1073/pnas.051635898 1:CAS:528:DC%2BD3MXis1KhsLk%3D 11274413 (Pubitemid 32249876)
21. M MacPhee KP Chepenik RA Liddell, et al. 1995 The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia Cell 81 6 957 966 10.1016/0092-8674(95)90015-2 1:CAS:528:DyaK2MXmsVagt7o%3D 7781071
22. T Matsumoto M Iida Y Kobori, et al. 2002 Genetic predisposition to clinical manifestations in familial adenomatous polyposis with special reference to duodenal lesions Am J Gastroenterol 97 1 180 185 10.1111/j.1572-0241.2002. 05434.x 11808944
23. T Matsumoto M Esaki R Yanaru-Fujisawa, et al. 2008 Small-intestinal involvement in familial adenomatous polyposis: evaluation by double-balloon endoscopy and intraoperative enteroscopy Gastrointest Endosc 68 911 919 10.1016/j.gie.2008.02.067 18561922
24. PI de Bakker R Yelensky I Pe'er, et al. 2005 Efficiency and power in genetic association studies Nat Genet 37 11 1217 1223 10.1038/ng1669 16244653 (Pubitemid 41568704)
25. K Heinimann B Mullhaupt W Weber, et al. 1998 Phenotypic differences in familial adenomatous polyposis based on APC gene mutation status Gut 43 675 679 1:STN:280:DyaK1M%2FntFamtA%3D%3D 9824350
26. S Nakamura T Matsumoto Y Kobori, et al. 2002 Impact of Helicobacter pylori infection and mucosal atrophy on gastric lesions in patients with familial adenomatous polyposis Gut 51 485 489 10.1136/gut.51.4.485 1:STN:280:DC%2BD38vpvFSqsA%3D%3D 12235068
27. JF Gebert C Dupon M Kadmon, et al. 1999 Combined molecular and clinical approaches for the identification of families with familial adenomatous polyposis coli Ann Surg 229 350 361 10.1097/00000658-199903000-00008 1:STN:280:DyaK1M7nsVKltw%3D%3D 10077047
28. YJ Won KJ Park HJ Kwon, et al. 1999 Germline mutations of the APC gene in Korean familial adenomatous polyposis patients J Hum Genet 44 103 108 10.1007/s100380050118 1:CAS:528:DyaK1MXhvVKqs7o%3D 10083733 (Pubitemid 29146932)
29. K Heinimann A Thompson A Locher, et al. 2001 Nontruncating APC germ-line mutations and mismatch repair deficiency play a minor role in APC mutation-negative polyposis Cancer Res 61 7616 7622 1:CAS:528: DC%2BD3MXnvFShtrs%3D 11606402
30. X Cao Y Hong KW Eu, et al. 2006 Singapore familial adenomatous polyposis (FAP) patients with classical adenomatous polyposis but undetectable APC mutations have accelerated cancer progression Am J Gastroenterol 101 2810 2817 10.1111/j.1572-0241.2006.00842.x 1:CAS:528:DC%2BD2sXht1aqtLk%3D 17026565 (Pubitemid 44902655)
31. TA Chan PJ Morin B Vogelstein, et al. 1998 Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis Proc Natl Acad Sci U S A 95 681 686 10.1073/pnas.95.2.681 1:CAS:528:DyaK1cXmtFaisQ%3D%3D 9435252 (Pubitemid 28083803)
32. Y Cao AT Pearman GA Zimmerman, et al. 2000 Intracellular unesterified arachidonic acid signals apoptosis Proc Natl Acad Sci U S A 97 11280 11285 10.1073/pnas.200367597 1:CAS:528:DC%2BD3cXnsF2rtbc%3D 11005842
33. T Hirabayashi T Shimizu 2000 Localization and regulation of cytosolic phospholipase A(2) Biochim Biophys Acta 1488 124 138 1:CAS:528: DC%2BD3cXotlGitro%3D 11080682
34. DH Adler JD Cogan JA Phillips 3rd, et al. 2008 Inherited human cPLA(2alpha) deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction J Clin Invest 118 2121 2131 1:CAS:528:DC%2BD1cXntVCmtLc%3D 18451993
35. K Takaku M Sonoshita N Sasaki, et al. 2000 Suppression of intestinal polyposis in Apc(delta 716) knockout mice by an additional mutation in the cytosolic phospholipase A(2) gene J Biol Chem 275 34013 34016 1:CAS:528:DC%2BD3cXotFWmtbk%3D 10969066
36. JN Ilsley M Nakanishi C Flynn, et al. 2005 Cytoplasmic phospholipase A2 deletion enhances colon tumorigenesis Cancer Res 65 7 2636 2643 10.1158/0008-5472.CAN-04-3446 1:CAS:528:DC%2BD2MXjtVeqsL8%3D 15805260 (Pubitemid 40490062)
37. M Enomoto M Konishi T Iwama, et al. 2000 The relationship between frequencies of extracolonic manifestations and the position of APC germline mutation in patients with familial adenomatous polyposis Jpn J Clin Oncol 30 82 88 10.1093/jjco/hyd017 1:STN:280:DC%2BD3c3ivFemug%3D%3D 10768871
38. S Akiba R Hatazawa K Ono, et al. 2001 Secretory phospholipase A2 mediates cooperative prostaglandin generation by growth factor and cytokine independently of preceding cytosolic phospholipase A2 expression in rat gastric epithelial cells J Biol Chem 276 21854 21862 10.1074/jbc.M010201200 1:CAS:528:DC%2BD3MXksFGksb0%3D 11274144
39. A Robert JE Nezamis C Lancaster, et al. 1979 Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury Gastroenterology 77 433 443 1:CAS:528:DyaE1MXls1yqsLw%3D 456839
40. K Kobayashi T Arakawa 1995 Arachidonic acid cascade and gastric mucosal injury, protection, and healing: topics of this decade J Clin Gastroenterol 21 Suppl 1 S12 S17 8774984